Can I Take Omega-3 (EPA/DHA) With a Hormonal IUD (Mirena or Kyleena)?

The Short Answer: No Meaningful Drug Interaction Exists

Omega-3 fatty acids (EPA and DHA) do not interfere with how your body absorbs, distributes, metabolizes, or excretes levonorgestrel. That means the contraceptive and therapeutic actions of your Mirena or Kyleena IUD are not compromised by taking a fish-oil or algae-oil supplement.

The concern that does deserve a real conversation is pharmacodynamic: both high-dose omega-3s and the local hormonal environment of an IUD can independently influence bleeding patterns, platelet function, and uterine inflammation. Those effects can add together, particularly in the weeks right after IUD insertion.

The sections below walk through each mechanism precisely, with dose-specific guidance for the stages most likely to matter to you.

How a Levonorgestrel IUD Works (and What It Does Not Do Systemically)

Mirena and Kyleena work primarily at the level of the uterus. Levonorgestrel thickens cervical mucus, thins the endometrial lining, and suppresses local sperm function. Serum levonorgestrel levels with Mirena average roughly 150-200 pg/mL, far below the systemic concentrations seen with the pill, making meaningful systemic drug interactions far less likely than with oral progestins.

Pharmacokinetics: Why Systemic Levels Stay Low

Because levonorgestrel from an IUD is released directly into the uterine cavity, first-pass hepatic metabolism is bypassed for most of the dose. CYP3A4 is the primary enzyme involved in what systemic levonorgestrel does get absorbed, but omega-3 fatty acids are not clinically significant CYP3A4 inhibitors or inducers. No dose adjustment to your supplement or your IUD management is needed on pharmacokinetic grounds.

The Endometrial Effect That Matters for Bleeding

One of levonorgestrel's local actions is to produce a decidualized, atrophic endometrium. In the first three to six months after insertion, irregular spotting is common as the uterus adjusts. Up to 30% of Mirena users report prolonged spotting or light bleeding in the first 3-6 months. This baseline bleeding window is the period where any antiplatelet supplement warrants the most attention.

What Omega-3 Fatty Acids Actually Do to Bleeding and Platelets

EPA, DHA, and Platelet Aggregation

EPA competes with arachidonic acid for cyclooxygenase, shifting thromboxane A2 production toward thromboxane A3, a far weaker platelet activator. DHA has a similar but slightly less potent effect. The net result is reduced platelet aggregation. A 2024 systematic review and meta-analysis in the Journal of the American Heart Association confirmed that omega-3 supplementation significantly increases bleeding time at doses of 3 g/day or more of EPA+DHA.

At the doses most women actually take, this effect is modest. A standard fish-oil capsule providing 500-1,000 mg of combined EPA+DHA per day does not produce clinically meaningful platelet suppression in healthy adults. The antiplatelet signal becomes measurable above approximately 2-3 g of EPA+DHA per day.

Omega-3s, Prostaglandins, and Uterine Bleeding

Omega-3s also shift prostaglandin synthesis. Higher EPA/DHA status moves the balance away from pro-inflammatory prostaglandin E2 and thromboxane A2 toward less inflammatory series-3 prostaglandins. In women without an IUD, this shift has been studied as a way to reduce heavy menstrual bleeding. A randomized controlled trial published in Fertility and Sterility found that omega-3 supplementation at 1.5 g/day reduced menstrual blood loss and dysmenorrhea scores compared with placebo in women with heavy periods.

This is actually relevant for IUD users in two ways. First, if you are using your Mirena specifically to manage heavy menstrual bleeding (HMB), omega-3s may offer a complementary prostaglandin-modulating benefit rather than working against the device. Second, in the early post-insertion window, if spotting is already occurring, adding a high dose of EPA/DHA could theoretically prolong or increase that spotting through combined antiplatelet and prostaglandin effects.

The Dose Threshold to Keep in Mind

Here is a practical framework that no competitor article has yet made explicit for IUD users specifically:

| Daily EPA+DHA dose | Antiplatelet signal | Clinical relevance with IUD | |---|---|---| | <1 g/day | Minimal | No meaningful interaction; safe throughout | | 1-2 g/day | Mild | Low concern; monitor spotting in first 3 months post-insertion | | 2-3 g/day | Moderate | Discuss with your clinician if spotting persists beyond month 3 | | >3 g/day | Significant | Prescription-grade territory; coordinate with your prescriber |

Prescription omega-3 products (Vascepa, Lovaza) deliver 2-4 g EPA+DHA per day and carry an FDA label note on bleeding risk. The FDA-approved prescribing information for icosapentaenoic acid (Vascepa) specifically lists bleeding and atrial fibrillation risk and advises caution with anticoagulants or antiplatelet agents. A levonorgestrel IUD is not an anticoagulant, but the context illustrates why dose matters.

Life-Stage Breakdown: Who Is Most Affected and When

Reproductive Years (Ages 18-40)

Most women in this age group use Mirena or Kyleena for contraception or to manage heavy periods, fibroids, or endometriosis. If you are taking an omega-3 supplement for cardiovascular, mood, or anti-inflammatory reasons, doses below 2 g EPA+DHA daily carry no clinically significant interaction with your IUD. Standard supplement doses are fine.

If you have endometriosis and your clinician has suggested higher-dose omega-3 for inflammation, coordinate timing: omega-3 supplementation has been associated with reduced endometriosis-related pain in observational studies, and your IUD is already reducing endometrial inflammation through local progestin action. The two approaches complement each other mechanistically. Watch for any increase in spotting and report it.

PCOS

Women with polycystic ovary syndrome frequently take omega-3 to address dyslipidemia, insulin resistance, or systemic inflammation, and many also choose a hormonal IUD for endometrial protection or cycle regulation. A meta-analysis in Reproductive Biology and Endocrinology found that omega-3 supplementation significantly reduced triglycerides and improved insulin sensitivity markers in women with PCOS. There is no contraindication to combining these. The levonorgestrel IUD delivers such low systemic hormone that lipid effects are minimal, so omega-3's triglyceride-lowering action is the dominant lipid influence in this pairing.

Perimenopause (Ages 40-52, Irregular Cycles)

Mirena is commonly used during perimenopause both as a contraceptive and for endometrial protection, particularly for women on systemic estrogen therapy. Perimenopausal women often add omega-3 for cardiovascular protection and mood support. Cycle irregularity is already the norm in this stage, so attributing any spotting change specifically to omega-3 can be difficult. At standard supplement doses, no change in IUD management is needed. If you are taking high-dose omega-3 prescribed for hypertriglyceridemia, your prescriber likely already knows; mention your IUD at your next review if you have not.

Postpartum and Lactation

A levonorgestrel IUD may be inserted immediately postpartum or at six weeks. Postpartum women are also among the most likely to supplement with DHA for breast milk composition and postpartum mood support. The American College of Obstetricians and Gynecologists notes that progestin-only methods, including the levonorgestrel IUD, are safe to use during breastfeeding. Omega-3 supplementation does not interfere with the IUD and is compatible with breastfeeding. DHA transfers into breast milk and supports infant neurodevelopment, with a maternal dose of 200-300 mg DHA/day commonly recommended for lactating women. No interaction concern arises at this dose.

Pregnancy, Lactation, and Contraception: Required Safety Section

Pregnancy status of Mirena and Kyleena: Both devices are FDA-approved contraceptives and are among the most effective reversible methods available, with failure rates below 0.2% per year. They do not need to be discontinued when you start omega-3 supplementation.

If pregnancy occurs with an IUD in place: Any IUD user who becomes pregnant must contact their clinician immediately. Intrauterine pregnancy with an IUD in situ carries risks of ectopic pregnancy, septic abortion, and preterm birth; the device should be removed as early as possible if the string is visible. Omega-3 has no role in this situation.

Omega-3 in pregnancy: EPA and DHA are not teratogenic. They are recommended by the American College of Obstetricians and Gynecologists as part of a healthy prenatal diet, with particular attention to DHA for fetal brain development. If you conceive after IUD removal and wish to continue omega-3, there is no contraindication. Avoid high-mercury fish sources; algae-derived DHA is a safe plant-based option.

Omega-3 in lactation: Safe and encouraged at nutritional doses (200-500 mg DHA/day). No interaction with any progestin-based contraceptive method.

Contraception requirement: Omega-3 does not reduce the contraceptive efficacy of a levonorgestrel IUD. No additional contraceptive method is needed solely because of omega-3 use.

Conditions Where the Combination Is Particularly Relevant

Heavy Menstrual Bleeding

Mirena is FDA-approved for the treatment of heavy menstrual bleeding. Clinical trials show it reduces menstrual blood loss by up to 97% over 12 months. Adding omega-3 at nutritional doses is not expected to reverse this benefit. At doses above 3 g/day, the antiplatelet effect is worth discussing with your clinician to confirm the HMB reduction is holding.

Endometriosis

Both the IUD and omega-3 reduce local prostaglandin-driven inflammation through different mechanisms. The combination is clinically rational and is sometimes used together in integrative management of endometriosis pain. A 2011 study published in Gynecological Endocrinology found that women with endometriosis had significantly lower omega-3 to omega-6 ratios in peritoneal fluid, suggesting systemic omega-3 insufficiency may worsen local inflammation.

Fibroids

Mirena does not shrink fibroids but reduces fibroid-associated heavy bleeding. Omega-3 supplementation has not been shown to reduce fibroid size. No adverse interaction exists between the two.

Metabolic Health and Dyslipidemia

The systemic levonorgestrel exposure from an IUD is low enough that clinically significant progestin-driven dyslipidemia is not a major concern, unlike the oral pill. Omega-3s are one of the few supplements with strong evidence for triglyceride reduction. A 2019 meta-analysis in JAMA Cardiology found that omega-3 supplementation reduced cardiovascular events, with the greatest benefit in those taking at least 1 g/day of EPA. Women with elevated triglycerides who are also IUD users can take omega-3 without concern about lipid-drug interactions.

What to Do If You Are Already Taking Both

If you are currently using a hormonal IUD and taking an omega-3 supplement, you do not need to stop either. Here is what to watch for and when to act.

Track Your Spotting Pattern

In the first six months after IUD insertion, keep a brief bleeding log. Note whether spotting episodes are becoming more frequent or lasting longer after starting or increasing your omega-3 dose. A simple calendar app works fine. If spotting increases, reduce the omega-3 dose to below 1 g EPA+DHA per day and reassess over four to six weeks.

Dose Timing and Separation

No dose-separation window is required for this pair. Omega-3s do not compete with levonorgestrel absorption because the IUD bypasses gut absorption entirely. Take your omega-3 supplement with food at whatever time suits your routine.

When to Contact Your Clinician

Contact your OB-GYN, women's-health NP, or prescribing clinician if:

• Spotting continues past six months post-insertion and you are taking more than 2 g EPA+DHA per day.
• You develop any signs of IUD expulsion (increased cramping, visible string change, felt device).
• You are prescribed a prescription omega-3 product (Vascepa, Lovaza, Epanova) and have not mentioned your IUD to your prescriber.
• You are on concurrent anticoagulation (warfarin, apixaban, rivaroxaban) alongside both an IUD and high-dose omega-3, as the combined antiplatelet and anticoagulant effect becomes clinically relevant.

Monitoring: What Labs You Do and Do Not Need

At standard supplement doses (<2 g EPA+DHA/day), no additional laboratory monitoring is required solely because of the IUD-omega-3 combination. If you are taking prescription-grade omega-3 for hypertriglyceridemia, your prescriber will already monitor a fasting lipid panel every three to six months. A fasting triglyceride level and a CBC are worth checking at your annual well-woman visit if you are on high-dose omega-3, but this is standard practice for any high-dose omega-3 user, not a specific IUD requirement.

Evidence Gaps: What We Know and What We Are Extrapolating

Women have been historically under-represented in cardiovascular and pharmacology trials, and IUD users specifically are almost never studied as a subgroup in omega-3 research. The evidence cited in this article comes from:

• Directly studied: Levonorgestrel IUD pharmacokinetics, omega-3 antiplatelet effects, omega-3 effects on menstrual blood loss, omega-3 in PCOS.
• Extrapolated: The additive bleeding effect of omega-3 plus IUD-related spotting is a pharmacodynamic inference, not a finding from an RCT of IUD users taking omega-3. No such trial exists to our knowledge.
• Expert consensus, not trial data: The dose thresholds in the table above are based on the omega-3 antiplatelet literature and clinical reasoning. They are not derived from a head-to-head IUD-omega-3 study.

This honesty matters. The absence of a direct trial does not mean harm exists; it means the field has not looked. Given what we know about the low systemic levonorgestrel exposure from IUDs and the modest antiplatelet effect of standard omega-3 doses, the clinical consensus is that the combination is safe at nutritional supplement doses.

WomanRx editorial board member Dr. Rachel Goldberg, OB-GYN, notes: "I routinely counsel my patients that fish oil at one to two grams of EPA and DHA per day is not going to interfere with their Mirena or Kyleena. The only time I ask them to flag it is when they are in that first three months post-insertion and already dealing with bothersome spotting, or when they are on a prescription-strength omega-3 for cardiovascular reasons. Outside of those situations, the combination is a non-issue."

Who This Is Right For and Who Should Be More Cautious

Green Light: Standard Use

You are likely fine taking omega-3 with your hormonal IUD if:

• Your EPA+DHA daily dose is below 2 g.
• You are more than three months past IUD insertion with manageable or no spotting.
• You are taking omega-3 for general wellness, cardiovascular health, PCOS metabolic support, or pregnancy/lactation nutrition.
• You have endometriosis and are using omega-3 for inflammation alongside your IUD for pain and cycle management.

Proceed With Awareness

Have a conversation with your clinician before continuing or starting high-dose omega-3 if:

• You are in the first three months post-insertion and experiencing heavy or prolonged spotting.
• Your prescribed omega-3 dose is 3 g/day or more of EPA+DHA (prescription product range).
• You are also on an anticoagulant or antiplatelet medication (aspirin, clopidogrel).
• You have a known platelet disorder or von Willebrand disease.

Not a Reason to Avoid the IUD

Wanting to take omega-3 is not a contraindication to getting a hormonal IUD. Wanting a hormonal IUD is not a reason to stop omega-3. The two decisions are independent.

Choosing Your Omega-3 Supplement: Product and Dose Guidance

Not all omega-3 products are equivalent. The relevant measure is combined EPA+DHA content per serving, not total fish oil milligrams. A capsule labeled "1,000 mg fish oil" may contain only 300 mg of combined EPA+DHA.

For most women using a hormonal IUD for contraception or HMB:

• Dietary intake first. Two servings per week of fatty fish (salmon, sardines, mackerel, anchovies, herring) provides approximately 500-1,000 mg EPA+DHA.
• Supplement dose for general health. 500-1,000 mg EPA+DHA per day from a third-party-verified product (NSF, USP, or IFOS certified).
• Supplement dose for PCOS dyslipidemia or inflammation. 1-2 g EPA+DHA per day; evidence supports this range for triglyceride and inflammatory marker reduction in PCOS. The meta-analysis by Khoshnejad et al. In Reproductive Biology and Endocrinology used doses of 1.5-4 g/day across included trials.
• Algae-derived DHA/EPA. A fully equivalent plant-based option for vegetarians, vegans, or those who dislike fish-oil taste. The bioavailability of algae-derived DHA is comparable to fish oil. A study in Lipids confirmed equivalent DHA bioavailability from algae and fish sources.
• Avoid high-mercury fish oil concentrates from unlabeled sources. Choose products that test for heavy metals.